Lawsuits over baby powder are no longer the only worry for Johnson & Johnson investors as pharmaceutical sales come under price and sales pressure.
View full coverage on Google Newsfrom Top stories - Google News https://on.wsj.com/2R6feCb
Subscribe to:
Post Comments
(
Atom
)
No comments :
Post a Comment